Amundi
MLAB icon

Amundi’s Mesa Laboratories MLAB Stock Holding History

Amundi’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-593
Closed -$67.9K – 1976
2025
Q1 		$67.9K Sell
593
-68
-10% -$9.27K ﹤0.01% 1791
2024
Q4 		$91K Buy
661
+297
+82% +$36.5K ﹤0.01% 1805
2024
Q3 		$45.6K Hold
364
– – ﹤0.01% 1850
2024
Q2 		$32.9K Hold
364
– – ﹤0.01% 1814
2024
Q1 		$36.3K Hold
364
– – ﹤0.01% 1871
2023
Q4 		$37.1K Hold
364
– – ﹤0.01% 1913
2023
Q3 		$36.9K Hold
364
– – ﹤0.01% 1897
2023
Q2 		$46.7K Sell
364
-178
-33% -$27.1K ﹤0.01% 1906
2023
Q1 		$92.4K Hold
542
– – ﹤0.01% 1758
2022
Q4 		$102K Buy
+542
New +$84.9K ﹤0.01% 1600

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM

Amundi's MLAB Position: Q2 2025 in Review

Amundi sold out of Mesa Laboratories (MLAB) in Q2 2025, closing a stake of 593 shares — an estimated $67.9K sold.

Amundi first reported a position in MLAB in Q4 2022 and held it in 10 quarters. The position peaked at $102K in Q4 2022. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2025.

  • Amundi reported no remaining Mesa Laboratories position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 593 Mesa Laboratories shares in Q2 2025, an estimated $67.9K.
  • Amundi first reported a position in Mesa Laboratories in Q4 2022 and held it in 10 quarters.
  • Amundi's Mesa Laboratories position peaked at $102K in Q4 2022.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.